COMPOSITION FOR TREATMENT OF THYROID ASSOCIATED OPHTHALMOPATHY, COMPRISING MESENCHYMAL STEM CELL

摘要

Provided is a composition comprising mesenchymal stem cells as an effective ingredient for prevention, alleviation, or treatment of thyroid associated ophthalmopathy. A pharmaceutical composition comprising mesenchymal stem cells as an effective ingredient for treatment of thyroid associated ophthalmopathy allows a patient with thyroid associated ophthalmopathy to recover from an increase in the abnormal hyaluronic acid production of orbital fibroblasts, lipocyte differentiation, and lipid accumulation, and thus can be useful for the treatment of thyroid associated ophthalmopathy.